Nonoperating Income (Expense) in USD of CAPRICOR THERAPEUTICS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CAPRICOR THERAPEUTICS, INC. quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2010 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $1.71M, a 278% increase year-over-year.
  • CAPRICOR THERAPEUTICS, INC. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $4.69M, a 131% increase year-over-year.
  • CAPRICOR THERAPEUTICS, INC. annual Nonoperating Income (Expense) for 2024 was $2.1M, a 17.2% increase from 2023.
  • CAPRICOR THERAPEUTICS, INC. annual Nonoperating Income (Expense) for 2023 was $1.79M, a 164% increase from 2022.
  • CAPRICOR THERAPEUTICS, INC. annual Nonoperating Income (Expense) for 2022 was $678K, a 26% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.69M $1.71M +$1.26M +278% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $3.43M $1.81M +$1.22M +206% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $2.22M $591K +$120K +25.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $2.1M $581K +$62K +11.9% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 $2.04M $453K -$20.8K -4.4% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $2.06M $591K +$211K +55.4% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 $1.85M $472K +$55.4K +13.3% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $1.79M $519K +$174K +50.3% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $1.62M $474K +$367K +344% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $1.25M $381K +$168K +79.3% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $1.08M $416K +$403K +2999% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $678K $345K +$156K +82.7% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 $522K $107K -$276K -72.1% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $798K $212K -$123K -36.6% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $920K $13.4K +$4.28K +46.6% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $916K $189K +$187K +7151% 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $729K $383K +$379K +9582% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $351K $335K +$331K +8971% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $19.4K $9.17K -$13.5K -59.6% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $32.9K $2.61K -$11.3K -81.3% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2022
Q3 2020 $44.3K $3.95K -$17.1K -81.2% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $61.4K $3.69K -$15.5K -80.8% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $76.9K $22.7K -$15.1K -40% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $92.1K $14K -$32.1K -69.7% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 $124K $21.1K -$14.7K -41.2% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $139K $19.2K -$20.2K -51.3% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $159K $37.8K +$23.2K +158% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $136K $46.1K -$15.5M -99.7% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 $15.7M $35.8K +$133K 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $15.5M $39.5K +$133K 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2018
Q1 2018 $15.4M $14.7K +$116K 01 Jan 2018 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $15.3M $15.6M +$17.2M 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$1.9M -$97.3K -$3.92K -4.2% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$1.89M -$93.5K -$17K -22.3% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$1.88M -$101K -$45.4K -81.7% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 -$1.83M -$1.6M -$1.54M -2523% 01 Oct 2016 31 Dec 2016 10-K 22 Mar 2018
Q3 2016 -$287K -$93.3K -$32K -52% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$255K -$76.5K -$14.9K -24.3% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$240K -$55.6K +$5.79K +9.43% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$246K -$61.2K -$149 -0.24% 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 -$245K -$61.4K -$2.51K -4.26% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$243K -$61.5K -$8.02K -15% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$235K -$61.4K -$36.2K -144% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$199K -$61K +$1.88M +96.9% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$2.08M -$58.9K -$7.71K -15.1% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$2.07M -$53.5K -$44K -464% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$2.03M -$25.2K -$40.4K -266% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 -$1.99M -$1.94M -$1.54M -385% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 -$446K -$51.2K -$61.3K -608% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$385K -$9.48K -$431K -102% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 $46K $15.2K +$17.2K 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $28.8K -$401K -$401K -69199% 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 $430K $10.1K -$2.21K -18% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $432K $421K +$422K 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 $10.6K -$2.01K -$3.82K -210% 01 Jan 2012 31 Mar 2012 10-Q 21 Jun 2013
Q4 2011 $14.4K $580 01 Oct 2011 31 Dec 2011 10-K 21 Jun 2013
Q3 2011 $12.3K +$9.05K +279% 01 Jul 2011 30 Sep 2011 10-Q 21 Jun 2013
Q2 2011 -$295 -$6.98K -104% 01 Apr 2011 30 Jun 2011 10-Q/A 10 Sep 2012
Q1 2011 $1.82K 01 Jan 2011 31 Mar 2011 10-Q/A 15 May 2012
Q3 2010 $3.24K 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 $6.69K 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

CAPRICOR THERAPEUTICS, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.1M +$307K +17.2% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $1.79M +$1.11M +164% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 $678K -$238K -26% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024
2021 $916K +$883K +2680% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 $32.9K -$59.1K -64.2% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 $92.1K -$43.9K -32.3% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 $136K -$15.2M -99.1% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $15.3M +$17.1M 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$1.83M -$1.58M -645% 01 Jan 2016 31 Dec 2016 10-K 22 Mar 2018
2015 -$246K -$46.9K -23.6% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2017
2014 -$199K +$1.79M +90% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$1.99M -$2.02M -7010% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 $28.8K +$14.4K +100% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
2011 $14.4K -$248K -94.5% 01 Jan 2011 31 Dec 2011 10-K 21 Jun 2013
2010 $262K 01 Jan 2010 31 Dec 2010 10-K 02 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.